| 000 | 01497 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250517131318.0 | ||
| 264 | 0 | _c20180322 | |
| 008 | 201803s 0 0 eng d | ||
| 022 | _a1876-4479 | ||
| 024 | 7 |
_a10.1093/ecco-jcc/jjw210 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJohnson, Laura A | |
| 245 | 0 | 0 |
_aOptimisation of Intestinal Fibrosis and Survival in the Mouse S. Typhimurium Model for Anti-fibrotic Drug Discovery and Preclinical Applications. _h[electronic resource] |
| 260 |
_bJournal of Crohn's & colitis _cJun 2017 |
||
| 300 |
_a724-736 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDrug Discovery |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibrosis _xdrug therapy |
| 650 | 0 | 4 |
_aIntestines _xpathology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMice, Inbred CBA |
| 650 | 0 | 4 | _aMice, Inbred DBA |
| 650 | 0 | 4 |
_aNipecotic Acids _xtherapeutic use |
| 650 | 0 | 4 |
_aSalmonella Infections, Animal _xcomplications |
| 650 | 0 | 4 | _aSalmonella typhimurium |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aRodansky, Eva S | |
| 700 | 1 | _aMoons, David S | |
| 700 | 1 | _aLarsen, Scott D | |
| 700 | 1 | _aNeubig, Richard R | |
| 700 | 1 | _aHiggins, Peter D R | |
| 773 | 0 |
_tJournal of Crohn's & colitis _gvol. 11 _gno. 6 _gp. 724-736 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/ecco-jcc/jjw210 _zAvailable from publisher's website |
| 999 |
_c26706510 _d26706510 |
||